Substituted pyrrolidines as G-protein coupled receptor 43 agonists
US10781171B2 · kind B2 · utility
0Cited by
5References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 17, 2020 |
| Grant date | Sep 22, 2020 |
| Priority date | — |
| Expiry date | Jan 17, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.